Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2017.7203 mmr-16-04-4521 Articles Amyloid β-42 induces neuronal apoptosis by targeting mitochondria HanXiao-Jian 1 2 * HuYang-Yang 1 2 * YangZhang-Jian 2 JiangLi-Ping 2 ShiSheng-Lan 1 3 LiYe-Ru 2 GuoMiao-Yu 1 WuHong-Li 3 WanYu-Ying 3 Research Institute of Ophthalmology and Visual Sciences, Affiliated Eye Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China Department of Pharmacology, School of Pharmaceutical Sciences, Nanchang University, Nanchang, Jiangxi 330006, P.R. China Department of Intra-Hospital Infection Management, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China Correspondence to: Dr Yu-Ying Wan, Department of Intra-Hospital Infection Management, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, Jiangxi 330006, P.R. China, E-mail: wanyy79@hotmail.com

Contributed equally

 102017 10082017 16 4 4521 4528 04102016 12062017 Copyright: © Han et al. 2017 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Alzheimer's disease (AD), with a typical pathological hallmark of amyloid-beta (Aβ)-containing plaques and neurofibrillary tangles, is one of the most common types of chronic neurodegenerative diseases. Aβ oligomers serve a crucial role in the pathogenesis of AD, and lead to neuronal loss. However, the precise mechanism of Aβ oligomers in AD remains to be elucidated. The present study demonstrated that 10 µM Aβ-42 activated the caspase signaling pathway, and induced significant apoptosis in primary cultured mouse cerebral cortical neurons. The results of reverse transcription-quantitative polymerase chain reaction and western blotting demonstrated that Aβ-42 (10 µM) also significantly upregulated the transcription and expression of the mitochondrial fission protein dynamin-related protein 1 (Drp1), and downregulated the transcription and expression of mitochondrial fusion proteins, including mitofusin 1/2 (Mfn1/2) and mitochondrial dynamin like GTPase (OPA-1). Neurons were transfected with pDsRed2-Mito for mitochondrial imaging, which revealed that 10 µM Aβ-42 induced mitochondrial fission in cortical neurons. In addition, 2′,7′-dichlorodihydrofluorescein diacetate and tetramethylrhodamine ethyl ester staining indicated that Aβ-42 increased the reactive oxygen species (ROS) level and reduced mitochondrial membrane potential in neurons. Inhibition of Drp1 activity by Mdivi-1 efficiently prevented Aβ-42-induced ROS production and disruption of mitochondrial membrane potential. Loss of mitochondrial membrane potential may activate PTEN-induced putative kinase 1 (Pink1), the prominent sensor for mitochondrial damage, and trigger the process of mitophagy to remove the damaged mitochondria. In the present study, western blotting revealed that the levels of autophagy marker microtubule-associated proteins 1A/1B light chain 3B (LC3B) and Pink1 were upregulated after Aβ-42 stimulation. In conclusion, these data indicated that Aβ-42 induces neuronal apoptosis by targeting mitochondria, including promotion of mitochondrial fission, disruption of mitochondrial membrane potential, increasing intracellular ROS level and activation of the process of mitophagy. Therefore, mitochondria may represent a potential therapeutic target for AD in the future.

 Amyloid β-42 mitochondria reactive oxygen species mitophagy apoptosis Introduction

Alzheimer's disease (AD) is one of the most common irreversible neurodegenerative disorders. The typical clinical features in AD are progressive cognitive and memory impairment (1). With the development of medicine, the average life span of the population continues to increase. However, AD is an age-associated disease; it was reported that in developed countries, it affects 7% of individuals aged >65, and 40% of individuals aged >80 (2,3). The estimated prevalence of AD in 2015 was 44 million people throughout the world, and it is estimated that this figure will double by 2050 (4). Unfortunately, there is still no effective therapy or vaccine for AD patients, despite decades of AD research. As a result, AD has become a serious health issue in the world (2). Therefore, it is urgent to investigate the underlying mechanism in the pathogenesis of AD. The neuropathological features of AD are the formation of amyloid β (Aβ) plaques, neurofibrillary tangles, and the progressive loss of synapses and neurons (5,6). Among these, Aβ plaques is most widely accepted as the root cause of AD. In the amyloid theory, the extracellular amyloid plaques damage synapses, induces neuronal cell death, and eventually leads to AD (6). Aβ plaques primarily consist of Aβ peptides yielded through the amyloidogenic pathway. Following the sequential enzymatic cleavage of β- and γ-secretases on amyloid precursor protein (APP), amyloid peptides of 39–43 amino acids and p3 are released from APP distributed in the neuronal membrane (1,7). Although p3 is not neurotoxic, it aggregates into fibers (8). Three main isoforms of Aβ are produced after β- and γ-secretase cleavage, including Aβ-40, Aβ-42 and Aβ-43. Of these, Aβ-42 and Aβ-43 are considered neurotoxic (9,10). Aβ-42 has been most studied, and is also widely accepted as the primary amyloidogenic form in AD (2).

Aβ peptides are hydrophobic with an intrinsic tendency to self-assemble to form aggregates. In aqueous solution, monomeric forms of Aβ peptide exhibit a random coil structure (11). However, Aβ peptides form different sizes and conformations of homodimers or oligomers with β-pleated sheet structures after incubation at 37°C for several days in a nucleation-dependent process, and Aβ-42 becomes the ‘seed’ in Aβ oligomers (12,13). It was reported that the mixture of monomeric and Aβ-42 oligomers is more toxic than monomeric, protofibrillar fractions or fibril (14). On the other hand, several studies have indicated that Aβ oligomers can directly incorporate into membranes and form pore-like structures (11,15,16). From observations in nuclear magnetic resonance, Aβ-42 pores consist of tetrameric and hexameric β-sheet subunits (16). The Aβ pore-like structures are selectively permeable to Ca2+. Thus, these pore-like structures formed by Aβ oligomeres are termed as ‘amyloid channels’. With high selective permeability for Ca2+, these ‘amyloid channels’ cause a rapid increase in [Ca2+]i, and disrupt the calcium homeostasis in neurons (17). Calcium homeostasis serves an important role in maintenance of neuronal synaptic plasticity, which is crucial for the process of memory formation (18). In the early stages of AD, the ‘amyloid channels’ constructed by Aβ oligomers disrupt calcium homeostasis, cause synaptic degeneration (synaptotoxicity), and lead to memory impairment. In addition, the Aβ oligomers are neurotoxic, and induce neuronal cell death in the later stage of AD (11). Although Aβ oligomers serve a crucial role in the pathogenesis of AD, there are some debates about its underlying mechanism. Therefore, the present study investigated whether Aβ-42 induces neuronal damage by targeting mitochondria.

Mitochondria serve an essential function in cells through the production of energy and the ability to regulate intracellular Ca2+. As such, they are involved in a variety of cellular processes, including survival, proliferation and apoptosis (19–21). Neurons with unique cellular processes heavily rely on mitochondria for energy supply, and are also sensitive to any defects in mitochondria. Mitochondria are also highly dynamic organelles and move through the cell with frequent fission and fusion events (22). Highly conserved dynamin-associated GTPases are identified as the mediator of mitochondrial dynamics. Dynamin-related protein 1 (Drp1) is involved in the process of mitochondrial fission, while mitofusin (Mfn)1/2 and mitochondrial dynamin like GTPase (OPA-1) are required for mitochondrial fusion in mammalian cells (23). Mitochondrial trafficking to pre- and postsynaptic sites serves an important role in control of basal synaptic transmission and plasticity (24,25). A decline in mitochondrial function is well recognized in neurodegenerative diseases and aging. Hirai et al (26) and Wang et al (27) observed that the quantity of mitochondria with normal morphology was decreased in AD neurons, whereas mitochondria with abnormal cristae was increased. On the other hand, there is an important quality control system, mitophagy, to remove those damaged mitochondria in cells. PTEN-induced putative kinase 1 (Pink1)/Parkin have been identified as crucial components of mitophagy (28). Pink1/Parkin acts as a sensor for mitochondrial quality, and is activated after the loss of matrix metalloproteinase (29,30). Furthermore, specific removal of individual damaged mitochondria seems to be supported by a fission process that separates healthy from defective organelles (31). However, whether Aβ oligomers induce neuronal apoptosis through promoting mitochondrial fission, disrupting MMP and activating mitophagy in AD remains to be further elucidated.

The present study established a primary culture of mouse cerebral cortical neurons, and stimulated neurons with 10 µM Aβ-42. It was demonstrated that Aβ-42 not only induced neuronal apoptosis by activating the caspase pathway, but also promoted mitochondrial fission, increased reactive oxygen species (ROS) production, disrupted MMP, and may activate the process of mitophagy by upregulation of microtubule-associated proteins 1A/1B light chain 3B (LC3B) and Pink1. Therefore, these data suggested that mitochondria may be an important potential target of Aβ-42 in the pathogenesis of AD.

 Materials and methods <sec> <title>Primary culture of mouse cerebral cortical neurons

C57BL/6 mice (n=60; 45 female, 15 male; age, 12 weeks; 24±3 g) were purchased from Hunan SJA Laboratory Animal Co., Ltd. (Changsha, China), and ethical approval was obtained from the Shanghai Animal Institution, Chinese Academy of Sciences (Shanghai, China). All mice were maintained at 20–25°C with 45–55% humidity, a 12-h light/dark cycle and free access to food and water. The pregnant female C57BL/6 mice on day 13 or 14 were anesthetized via an intraperitoneally injection of 5 mg/100 g pentobarbital solution. The cerebral cortex from the ~13–14-embryonic day fetal C57BL/6 mice was then removed under aseptic conditions, and treated with 0.125% trypsin (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 0.004% DNase-I (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) at 37°C for 15 min and mechanically dissociated. The cerebral cortical neurons were plated on poly-L-lysine (Sigma-Aldrich; Merck KGaA) and laminin (Roche Diagnostics, Indianapolis, IN, USA)-coated glass bottomed or plastic-bottomed 35-mm culture dishes. Cell density was ~25,000–30,000/35-mm dish for microscopy or ~45,000–50,000/35-mm dish for western blotting. Cultures were maintained in neurobasal plating media supplemented with B27 Supplement (1 ml/50 ml), 0.5 mM Glutamine solution, 25 µM Glutamate, 100 µg/ml penicillin-streptomycin (P/S), 1 mM HEPES and 10% fetal bovine serum (FBS) at 37°C in 5% CO2. On the second day, half the volume of culture media was replaced with same volume of neurobasal feeding media [Neurobasal Media containing B27 Supplement (1 ml/50 ml), 0.5 mM Glutamine solution, 100 µg/ml P/S and 1 mM HEPES]. The medium, B27 supplement, Glutamine, FBS and P/S were from Invitrogen; Thermo Fisher Scientific, Inc. Subsequently, neurons were fed every 4 days by replacing half of the old media with same volume of neurobasal feeding media. Cultures were used for experiments on days 9–11.

 Preparation of Aβ-42 peptide

Aβ-42, a toxic peptide fragment derived from APP, was purchased from Sigma-Aldrich; Merck KGaA as previously described (32). Aβ-42 peptide was resuspended in dimethyl sulfoxide (Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) to 5 mM and then diluted to 100 µM in sterile PBS (pH 7.4). The suspension was allowed to oligomerize for 5 days at 37°C, and then diluted to the desired concentrations immediately before being added to the cell culture medium.

 Neuronal apoptosis assay

Firstly, mouse cerebral cortical neuronal cultures were exposed to 0, 2.5, 5 or 10 µM Aβ-42, and the morphology of neurons was observed under microscope at 0, 12 and 24 h after treatment with Aβ-42. To detect the apoptotic neurons, Hoechst 33258 staining was conducted. In brief, the neurons were washed with PBS at 24 h after incubation with Aβ-42, and fixed with 4% paraformaldehyde for 10 min. To label neurons, immunofluorescence staining was performed with a microtubule-associated protein 2 (anti-MAP2; cat. no. 8707; 1:200; Cell Signaling Technology, Inc., Danvers, MA, USA) primary antibody for 2 h at room temperature and an Alexa Fluor 488-conjugated goat anti-rabbit secondary fluorescence antibody (cat. no. SA00006-2; 1:200; ProteinTech Group, Inc., Chicago, IL, USA) for 1 h at room temperature. Cells were stained with Hoechst 33258 (cat. no. 94403; Sigma-Aldrich; Merck KGaA) for 5 min at room temperature for nucleus staining according to the manufacturer's protocol. Fluorescence of MAP2 and Hoechst 33258 were detected and analyzed under a fluorescence microscope (Olympus Corporation, Tokyo, Japan). Neurons with condensed Hoechst 33258 were counted as dead cells.

 Western blot analysis

After treatment with Aβ-42, neurons were harvested and lysed in radioimmunoprecipitation assay lysis buffer (Beijing Solarbio Science & Technology Co., Ltd.) according to the manufacturer's protocol. Protein concentrations in whole cell lysates were determined using a bicinchoninic acid assay kit (Thermo Fisher Scientific, Inc.). Whole cell lysates were mixed with an equal volume of 2X loading buffer (cat. no. P1019; Beijing Solarbio Science & Technology Co., Ltd.), sonicated, boiled for 5 min and stored at −20°C prior to use. A total of 20 µg protein for each sample was separated by 8% SDS-PAGE, and transferred onto a PVDF membrane (Millipore, Massachusetts, USA). The membrane was blocked with 5% skim milk in TBS with 0.1% Tween-20 (TBST) buffer for 1 h at room temperature, and then incubated for 2 h at room temperature with the following primary antibodies: Rabbit anti-Caspase-3 (cat. no. 9662), anti-Drp1 (cat. no. 8570), anti-Mfn2 (cat. no. 9482), anti-LC3B (cat. no. 3868) and anti-Pink1 (cat. no. 6946) (all from Cell Signaling Technology, Inc.; 1:1,000), rabbit anti-Mfn1 (cat. no. ab104274) and anti-OPA-1 (cat. no. ab42364; both from Abcam, Cambridge, UK; 1:1,000), and rabbit anti-GAPDH (cat. no. sc-25778; Santa Cruz Biotechnology, Dallas, TX, USA; 1:1,000). After three washes with TBST, the membranes were further incubated with a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (cat. no. HS101; Beijing TransGen Biotech, Co., Beijing, China; 1:2,000) for 2 h at room temperature. A chemiluminescence assay was performed with Amersham Enhanced Chemiluminescence Prime Western Blotting Detection reagents (CWBIO, Beijing, China). The immunoblot signal was detected using the Molecular Imager®Chemi DOCTXRS+ system (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and the density of each band was analyzed using ImageJ software (version 2006.02.01; National Institutes of Health, Bethesda, MD, USA).

 Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

After treatment with Aβ-42, neurons were harvested, and total RNA was extracted using an RNA simple Total RNA kit (Tiangen Biotech Co., Ltd., Beijing, China). Total RNA was reverse-transcribed using PrimeScript™ RT reagent kit with gDNA Eraser. qPCR was performed using SYBR® Premix Ex TaqTM II on a 7,500 Real Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.). Relative quantification of gene expression was calculated using the formula 2−∆∆Cq, ∆∆Cq=(Cqtarget gene-CqGAPDH)A,β-42-(Cqtarget gene-CqGAPDH)control (33). qPCR was performed with the following primer sequences: Forward, 5′-CAGGAATTGTTACGGTTCCCTAA-3′ and reverse, 5′-CCTGAATTAACTTGTCCCGTGA-3′ for Drp1; forward, 5′-AACTTGATCGAATAGCATCCGAG-3′ and reverse, 5′-GCATTGCATTGATGACAGAGC-3′ for Mfn1; forward, 5′-CTGGGGACCGGATCTTCTTC-3′ and reverse, 5′-CTGCCTCTCGAAATTCTGAAACT-3′ for Mfn2; forward, 5′-CGACTTTGCCGAGGATAGCTT-3′ and reverse, 5′-CGTTGTGAACACACTGCTCTTG-3′ for OPA-1; and forward, 5′-AGCCAAAAGGGTCATCATCT-3′ and reverse, 5′-GGGGCCATCCACAGTCTTCT-3′ for GAPDH. The PCR thermocycling conditions were as follows: 94°C for 30 sec, followed by 40 cycles of 94°C for 5 sec, 60°C for 15 sec and 72°C 10 sec. Three independent experiments for each condition were performed.

 Mitochondrial imaging

As described previously (34), pDsRed2-Mito (Clontech Laboratories, Inc., Mountainview, CA, USA) was transfected into mouse cerebral cortical neurons to label mitochondria with Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). At 24 h after transfection, mitochondrial morphology was observed in live-cell imaging with an inverted fluorescence microscope with an excitation wavelength of 545 nm. After Aβ-42 treatment for 12 h, mitochondrial morphology in neurons was continuously detected for 1 h under a fluorescence microscope.

 Detection of the intracellular ROS level

Neuronal cultures on days 9–11 were used for experiments. To examine the effect of Drp1-dependent mitochondrial fission on Aβ-42-induced intracellular ROS production, neurons were pretreated with 5 µM Mdivi-1 (Sigma-Aldrich; Merck KGaA) for 2 h prior to 10 µM Aβ-42 treatment. To detect the intracellular ROS level, cells were incubated with 10 µM of the fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA; Sigma-Aldrich; Merck KGaA) for 30 min at 37°C in the dark. After incubation, the cells were washed twice with PBS. Fluorescence signals of ROS were detected with excitation and emission wavelengths at 488/525 nm under a fluorescence microscope.

 Measurement of mitochondrial membrane potential (∆ψm)

The mitochondrial membrane potential (∆ψm) of cells was measured using tetramethylrhodamine ethyl ester (TMRE; Invitrogen; Thermo Fisher Scientific, Inc.), a potentiometric, cell-permeable fluorescent indicator that accumulates in the highly negatively charged interior of mitochondria. To examine the effect of Drp1-dependent mitochondrial fission on Aβ-42 induced intracellular ROS production, neurons were pretreated with 5 µM Mdivi-1 for 2 h prior to 10 µM Aβ-42 treatment. According to the manufacturer's protocol, cells were incubated with 50 nM TMRE for 20 min at 37°C. After incubation, the cells were washed twice with PBS. Fluorescence signals of MMP (∆ψm) were detected under a fluorescence microscope with excitation and emission wavelengths of 540 and 575 nm, respectively.

 Statistical analysis

Data are presented as the mean ± standard deviation. Statistical analysis was performed using SPSS 17.0 (SPSS, Inc., Chicago, IL, USA). Data were analyzed by one-way analysis of variance followed by planned comparisons of multiple conditions, and P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Aβ-42 induces neuronal apoptosis by activating the caspase pathway

Firstly, the primary cultured mouse cerebral cortical neurons were treated with 0, 2.5, 5 and 10 µM of Aβ-42. The morphology of neurons was observed under microscope at 0, 12 and 24 h after Aβ-42 treatment. As presented in Fig. 1, there were no significant changes in neuronal shape after 0, 2.5 and 5 µM Aβ-42, whereas obvious damage in the neuronal shape occurred at 24 h after 10 µM Aβ-42. Neuronal apoptosis was also detected using Hoechst 33258 and MAP2 staining. It was observed that there was little detectable neuronal death 24 h after 0 and 5 µM Aβ-42. In contrast, treatment with 10 µM Aβ-42 resulted in significant neuronal death (Fig. 2A and B). In addition, Caspase-3 is a critical executioner of apoptosis, and proteolytic cleavage of its zymogen is important for activation of Caspase-3. From western blotting, it was demonstrated that treatment with 10 µM Aβ-42 also led to significantly cleaved Caspase-3 in neurons (Fig. 2C and D). These results indicated that 10 µM Aβ-42 induces neuronal apoptosis by activating the Caspase pathway.

 Effect of Aβ-42 on transcription and expression of mitochondrial fission and fusion proteins in neurons

To investigate the possible role of mitochondrial dynamics in Aβ-42-induced neuronal apoptosis, the transcription and expression level of mitochondrial fission and fusion proteins in neurons was examined by RT-qPCR and western blotting assays. The mRNA and protein expression levels of the mitochondrial fission protein, Drp1, were upregulated from 6 to 36 h post-treatment with 10 µM Aβ-42. In contrast, the transcription and expression of both mitochondrial outer membrane fusion proteins (Mfn1 and Mfn2) and the inner membrane fusion protein OPA1 was down-regulated at 12~36 h after 10 µM Aβ-42 (Fig. 3). These results suggested that mitochondrial fission or fusion events might be influenced by Aβ-42 stimulation, and implicate the possible role of mitochondrial dynamics in Aβ-42-induced neuronal apoptosis.

 Aβ-42 promotes mitochondrial fission and intracellular ROS production in neurons

Based on the alteration in expression of mitochondrial fission and fusion proteins, mitochondrial morphology in neurons was further examined pre- and post-Aβ-42 treatment. Cultured cortical neurons were transfected with pDsRed2-Mito to label mitochondria. The morphology of mitochondria was monitored using live-cell imaging. As previously demonstrated, mitochondria are localized to neuronal axons and dendrites, and exhibit an elongated, tubular and threadlike shape (35). After treatment with 10 µM Aβ-42, elongated mitochondria became much more fragmented and shorter in morphology (Fig. 4A), indicating that 10 µM Aβ-42 induced mitochondrial fission in neurons. Although the sources of intracellular ROS include the mitochondrial electron transport chain (ETC), NADPH oxidases, xanthine oxidases, cyclooxygenases and lipoxygenases, electron leak from mitochondrial ETC is the major source of ROS. To examine the effect of Aβ-42 on mitochondrial function, the ROS level in neurons was measured using DCFH-DA staining. As presented in Fig. 4B, 10 µM Aβ-42 markedly increased the intracellular ROS level. Inhibition of Drp1 activity with Mdivi-1 efficiently attenuated Aβ-42-induced ROS production. These results suggested that Aβ-42 might disturb mitochondrial respiration through promoting excessive mitochondrial fission.

 Aβ-42 disrupts mitochondrial membrane potential and upregulates LC3B and Pink1 expression levels

The effect of Aβ-42 on mitochondrial membrane potential was measured using TMRE staining. Compared with the control, 10 µM Aβ-42 markedly decreased mitochondrial membrane potential in neurons. In contrast, inhibition of Drp1 activity by pre-treatment with Mdivi-1 efficiently restored mitochondrial membrane potential after Aβ-42 (Fig. 5A). As loss of mitochondrial membrane potential is the crucial initiating signal to trigger the process of mitophagy, the protein expression levels of the autophagy marker LC3B and the mitophagy sensor Pink1 were examined after Aβ-42 treatment by western blotting assay. As presented in Fig. 5B and C, the expression levels of LC3B and Pink1 in neurons was dramatically up-regulated at 12~36 h post-treatment with 10 µM Aβ-42. These results suggested that Aβ-42 stimulation may disrupt mitochondrial membrane potential, and possibly activate the process of mitophagy to remove the damaged and defective mitochondria in neurons.

 Discussion

AD, a neurodegenerative disorder, remains the most common cause of dementia. The prevalence of has AD become a serious health issue in the ageing population worldwide (4). It is well recognized that amyloid peptides serve a crucial role in the formation of Aβ plaques, neurofibrillary tangles and progressive loss of synapses and neurons. Among these main amyloid peptides, Aβ-42 has been identified as the most neurotoxic, especially the Aβ-42 oligomers. The soluble Aβ oligomers incorporate into cellular membrane to construct ‘amyloid channels’ which are permeable to Ca2+. As a result, ‘amyloid channels’ disrupt the calcium homeostasis in neurons (36). Calcium dyshomeostasis by these channels leads to impairment of synaptic plasticity and eventually loss of neurons. In addition, it has been reported that Aβ-42 can induce mitochondrial mis-localization. After Aβ-42 treatment, mitochondria are reduced in axons and dendrites, and accumulate in the soma of neurons (37). Oligomeric and fibrillar Aβ-42 also induces mitochondrial dysfunctions in cortical neurons, including a reduction in mitochondrial membrane potential, state 3 respiration, respiratory control ratio and uncoupled respiration (38). Consistent with a previous study (39), the present study demonstrated that Aβ-42 induced significant neuronal apoptosis, and activated the Caspase pathway. Ca2+ is an active second messenger, and is involved in many cellular processes. Previous studies have indicated that calcium impacts on mitochondria, including mitochondrial functions and its dynamics (23,34). To investigate whether Aβ-42 induces damage to neurons by targeting mitochondria, mitochondrial morphology and the expression of mitochondrial fission and fusion proteins were examined. It was demonstrated that expression of the mitochondrial fission protein Drp1 was upregulated after Aβ-42 treatment. Mitochondrial fusion proteins Mfn1/2 and OPA1 were downregulated after Aβ-42 treatment. Consistent with the alteration in expression of mitochondrial fission and fusion proteins, Aβ-42 induced obvious mitochondrial fission in neurons. These results imply the possibility that Aβ-42 might induce neuronal apoptosis through disrupting mitochondrial dynamics, promoting mitochondrial fission in neurons.

The most important functions of mitochondria include ATP synthesis through oxidative phosphorylation, regulation of redox, calcium buffering and the control of apoptosis in response to extracellular and intracellular stimulation or stress (40). In all cell types, neurons have high energy consumption for maintenance of their functions. Mitochondria are often recruited to subcellular regions with high metabolic requirements, for example in the active or growth cones. In healthy neurons, mitochondria are abundant at neuronal processes, including synapses and axons, and are involved in regulation of neuronal activity, synaptic plasticity and neurotransmitter release (41). As a result, neurons are particularly vulnerable to mitochondrial defects. Neuronal apoptosis is often accompanied by disruption in mitochondrial dynamics and functions. Mitochondrial fission is an early event during apoptosis, and inhibition of mitochondrial fission by silencing Drp1, and overexpression of dominant negative mutant Drp1-K38A or chemical Drp1 inhibitor Mdivi-1 efficiently reduces apoptosis (42). In contrast, mitochondrial fusion protects cells against apoptosis. It has been reported that OPA-1, the inner mitochondrial membrane fusion protein, serves a crucial role in regulation of the structure and tightness of mitochondrial cristae junctions. Most cytochrome C molecules are encapsulated within the folds of the mitochondrial intermembrane space. Cristae junctions sealed by the complex of OPA-1 oligomers prevent leakage of cytochrome C from mitochondria. Thus, knocking down OPA-1 remodels cristae junctions, increases cytochrome C release and sensitizes cells to apoptosis (42). In addition, it has also been reported that outer mitochondrial membrane fusion protein Mfn1 and 2 interact with Bcl-2 X-associated protein and Bcl-2 homologous antagonist killer in regulation of mitochondrial morphology and apoptosis (43). This is consistent with the results of the present study; Aβ-42 stimulation upregulated the expression of Drp1, decreased the level of OPA-1, Mfn1 and 2, promoted mitochondrial fission and increased neuronal apoptosis.

It has been reported that excessive fission and cristae remodeling constantly coincide with mitochondrial membrane permeability (44,45). Alteration of mitochondrial membrane permeability leads to certain defects in mitochondrial functions. One of them is the loss of the electric potential across the inner mitochondrial membrane. The present study demonstrated that the mitochondrial membrane potential in neurons was decreased after treatment with Aβ-42. Inhibition of Drp1 activity by Mdivi-1 efficiently attenuated Aβ-42-induced disruption of mitochondrial membrane potential. These results suggested that Drp1-dependent mitochondrial fission is involved in the disruption of mitochondrial membrane potential after Aβ-42. Loss of mitochondrial membrane potential results in serious damage to mitochondrial functions, and is also an important initiating signal to trigger mitophagy. Mitophagy is a variant of autophagy to remove the damaged mitochondria. In case of specific elimination of damaged mitochondria, mitophagy requires a specific labeling and autophagosome recruitment system, involving Pink1/Parkin. Pink1 is the prominent sensor for mitochondria, and accumulates at the surface of damaged mitochondria, especially at potential-deficient mitochondria. Pink1 subsequently recruits and activates Parkin, and conjugates ubiquitin to various outer mitochondrial membrane proteins (29,30,46). Ubiquitin and autophagic protein LC3 binding with some adaptor proteins sequestrate the damaged mitochondria in the autophagosomal membrane, and then fuses with a lysosome for degradation (28). In the present study, it was demonstrated that Aβ-42 upregulated the expression of both Pink1 and LC3B. Although the underlying mechanism remains to be elucidated, these data imply that Aβ-42 stimulation may trigger the process of mitophagy to remove the damaged mitochondria in neurons.

In conclusion, the present study demonstrated that Aβ-42 treatment activated the Caspase signaling pathway, and induced obvious neuronal apoptosis. Although the role of Aβ-42 in neuronal survival has been described (14,39), to the best of our knowledge, these data demonstrated for the first time that Aβ-42 increases mitochondrial fission by changing the expression of mitochondrial fission and fusion proteins. Inhibition of Drp1-dependent mitochondrial fission efficiently suppressed Aβ-42-induced intracellular ROS production and loss of mitochondrial membrane potential in neurons. Furthermore, Aβ-42 may trigger the process of mitophagy to remove the damaged mitochondria through upregulating expression of the autophagy marker LC3B and the mitophagy sensor Pink1. Although the underlying mechanism of how Aβ-42 targets mitochondria remains to be elucidated, the present study suggested mitochondria may represent a potential therapeutic target for AD in the future.

 Acknowledgements

The present study was supported by the National Natural Science Foundation of China (grant no. 31360241), Natural Science Foundation of Jiangxi (grant no. 20161ACB20019), the Postgraduate Student Foundation for New Teacher from the Ministry of Education of China (grant no. 20123601120001) and the Foundation from Education Department of Jiangxi Province (grant no. GJJ13162).

 References Mendiola-PrecomaJBerumenLCPadillaKGarcia-AlcocerGTherapies for prevention and treatment of Alzheimer's diseaseBiomed Res Int20162589276201610.1155/2016/2589276275477564980501 ArborSCLaFontaineMCumbayMAmyloid-beta Alzheimer targets-protein processing, lipid rafts, and amyloid-beta poresYale J Biol Med895212016275050134797837 GlassCKSaijoKWinnerBMarchettoMCGageFHMechanisms underlying inflammation in neurodegenerationCell140918934201010.1016/j.cell.2010.02.016203038802873093 Van CauwenbergheCVan BroeckhovenCSleegersKThe genetic landscape of Alzheimer disease: Clinical implications and perspectivsGenet Med18421430201610.1038/gim.2015.11726312828 IngelssonMFukumotoHNewellKLGrowdonJHHedley-WhyteETFroschMPAlbertMSHymanBTIrizarryMCEarly Abeta accumulation and progressive synaptic loss, gliosis and tangle formation in AD brainNeurology62925931200410.1212/01.WNL.0000115115.98960.3715037694 LiQLiuYSunMAutophagy and Alzheimer's DiseaseCell Mol Neurobiol37377388201710.1007/s10571-016-0386-827260250 BarageSHSonawaneKDAmyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's diseaseNeuropeptides52118201510.1016/j.npep.2015.06.00826149638 DulinFLéveilléFOrtegaJBMornonJPBuissonACallebautIColloc'hNP3 peptide, a truncated form of A beta devoid of synaptotoxic effect, does not assemble into soluble oligomersFEBS Lett58218651870200810.1016/j.febslet.2008.05.00218474239 HolmesCBocheDWilkinsonDYadegarfarGHopkinsVBayerAJonesRWBullockRLoveSNealJWLong-term effects of Abeta42 immunisation in Alzheimer's disease: Follow-up of arandomised, placebo-controlled phase I trialLancet372216223200810.1016/S0140-6736(08)61075-218640458 SaitoTSuemotoTBrouwersNSleegersKFunamotoSMihiraNMatsubaYYamadaKNilssonPTakanoJPotent amyloidogenicity and pathogenicity of Aβ43Nat Neurosci1410231032201110.1038/nn.285821725313 KawaharaMOhtsukaIYokoyamaSKato-NegishiMSadakaneYMembrane incorporation, channel formation and disruption of calcium homeostasis by alzheimer's β-amyloid proteinInt J Alzheimers Dis20113045832011215472253087492 KawaharaMNeurotoxicity of β-amyloid protein: Oligomerization, channel formation and calcium dyshomeostasisCurr Pharm Des1627792789201010.2174/13816121079317654520698821 JarrettJTLansburyPTJrSeeding ‘one-dimensional crystallization’ of amyloid: A pathogenic mechanism in Alzheimer's disease andscrapie?Cell7310551058199310.1016/0092-8674(93)90635-48513491 JanAAdolfssonOAllamanIBuccarelloALMagistrettiPJPfeiferAMuhsALashuelHAAbeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 speciesJ Biol Chem28685858596201110.1074/jbc.M110.17241121156804 MirzabekovTLinMCYuanWLMarshallPJCarmanMTomaselliKLieberburgIKaganBLChannel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptideBiochem Biophys Res Commun20211421148199410.1006/bbrc.1994.20477519420 StrodelBLeeJWWhittlestonCSWalesDJTransmembrane structures for Alzheimer's Aβ(1–42) oligomersJ Am Chem Soc1321330013312201010.1021/ja103725c20822103 DemuroAMinaEKayedRMiltonSCParkerIGlabeCGCalcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism ofsoluble amyloid oligomersJ Biol Chem2801729417300200510.1074/jbc.M50099720015722360 FosterTCCalcium homeostasis and modulation of synaptic plasticity in the aged brainAging Cell6319325200710.1111/j.1474-9726.2007.00283.x17517041 OakesSAKorsmeyerSJUntangling the web: Mitochondrial fission and apoptosisDev Cell7460462200410.1016/j.devcel.2004.09.01015469833 SzabadkaiGSimoniAMChamiMWieckowskiMRYouleRJRizzutoRDrp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosisMol Cell165968200410.1016/j.molcel.2004.09.02615469822 ShawJMNunnariJMitochondrial dynamics and division in budding yeastTrends Cell Biol12178184200210.1016/S0962-8924(01)02246-2119785373785940 WanYYZhangJFYangZJJiangLPWeiYFLaiQNWangJBXinHBHanXJInvolvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cellsOncol Rep32619626201410.3892/or.2014.323524899388 ChanDCMitochondrial fusion and fission in mammalsAnnu Rev Cell Dev Biol227999200610.1146/annurev.cellbio.22.010305.10463816704336 TangYZuckerRSMitochondrial involvement in post-tetanic potentiation of synaptic transmissionNeuron18483491199710.1016/S0896-6273(00)81248-99115741 LiZOkamotoKHayashiYShengMThe importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapsesCell119873887200410.1016/j.cell.2004.11.00315607982 HiraiKAlievGNunomuraAFujiokaHRussellRLAtwoodCSJohnsonABKressYVintersHVTabatonMMitochondrial abnormalities in Alzheimer's diseaseJ Neurosci2130173023200111312286 WangXSuBZhengLPerryGSmithMAZhuXThe role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's diseaseJ Neurochem109Suppl 1S153S159200910.1111/j.1471-4159.2009.05867.x RübCWilkeningAVoosWMitochondrial quality control by the Pink1/Parkin systemCell Tissue Res367111123201710.1007/s00441-016-2485-827586587 MatsudaNSatoSShibaKOkatsuKSaishoKGautierCASouYSSaikiSKawajiriSSatoFPINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagyJ Cell Biol189211221201010.1083/jcb.200910140204041072856912 NarendraDPJinSMTanakaASuenDFGautierCAShenJCooksonMRYouleRJPINK1 is selectively stabilized on impaired mitochondria to activate ParkinPLoS Biol8e1000298201010.1371/journal.pbio.1000298201262612811155 YouleRJvan der BliekAMMitochondrial fission, fusion and stressScience33710621065201210.1126/science.1219855229367704762028 CamilleriAZarbCCaruanaMOstermeierUGhioSHögenTSchmidtFGieseAVassalloNMitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenolsBiochim Biophys Acta182825322543201310.1016/j.bbamem.2013.06.02623817009 LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) methodMethods25402408200110.1006/meth.2001.126211846609 HanXJLuYFLiSAKaitsukaTSatoYTomizawaKNairnACTakeiKMatsuiHMatsushitaMCaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphologyJ Cell Biol182573585200810.1083/jcb.200802164186950472500141 HanXJLuYFLiSATomizawaKTakeiKMatsushitaMMatsuiHInvolvement of calcineurin in glutamate-induced mitochondrial dynamics in neuronsNeurosci Res60114119200810.1016/j.neures.2007.09.01218045716 LinHBhatiaRLalRAmyloid beta protein forms ion channels: Implications for Alzheimer's disease pathophysiologyFASEB J1524332444200110.1096/fj.01-0377com11689468 Iijima-AndoKHearnSAShentonCGattAZhaoLIijimaKMitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's diseasePLoS One4e8310200910.1371/journal.pone.0008310200168332790372 EckertAHauptmannSScherpingIMeinhardtJRheinVDröseSBrandtUFändrichMMüllerWEGötzJOligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301 L tau transgenic miceJ Mol Med (Berl)8612551267200810.1007/s00109-008-0391-618709343 WangZJZhouBMaoWWYinMOverexpression of 5-lipoxygenase increases the neuronal vulnerability of PC12 cells to Aβ42Yakugaku Zasshi13118431853201110.1248/yakushi.131.184322129883 NakamuraTLiptonSARedox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: Potential implications for Alzheimer's and Parkinson's diseasesApoptosis1513541363201010.1007/s10495-010-0476-x201779702978885 BüelerHMitochondrial dynamics, cell death and the pathogenesis of Parkinson's diseaseApoptosis1513361353201010.1007/s10495-010-0465-020131004 LeeYJJeongSYKarbowskiMSmithCLYouleRJRoles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1 and Opa1 in apoptosisMol Biol Cell1550015011200410.1091/mbc.E04-04-029415356267524759 BrooksCWeiQFengLDongGTaoYMeiLXieZJDongZBak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusinsProc Natl Acad Sci USA1041164911654200710.1073/pnas.0703976104176069121913853 LandesTMartinouJCMitochondrial outer membrane permeabilization during apoptosis: The role of mitochondrial fissionBiochim Biophys Acta1813540545201110.1016/j.bbamcr.2011.01.02121277336 CosentinoKGarcía-SáezAJMitochondrial alterations in apoptosisChem Phys Lipids1816275201410.1016/j.chemphyslip.2014.04.00124732580 SarrafSARamanMGuarani-PereiraVSowaMEHuttlinELGygiSPHarperJWLandscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarizationNature496372376201310.1038/nature12043235036613641819

Effect of Aβ-42 at different concentrations on mouse cerebral cortical neurons. Representative fluorescence microscopy images of mouse cerebral cortical neurons (10 days in vitro) exposed to Aβ-42. Scale bar=20 µm. Aβ-42, amyloid β-42.

Aβ-42-induced cortical neuronal apoptosis and activated caspase pathway. (A) Representative fluorescence microscopy images and (B) quantification of neuronal apoptosis of mouse cerebral cortical neurons (10 days in vitro) exposed to Aβ-42 and stained with Hoechst 33258 and MAP2. Scale bar=50 µm. (C) Representative western blot images and (D) quantification of caspase 3 protein expression levels. Data are presented as the mean ± standard deviation of at least three independent experiments. *P<0.05 vs. 0 h, **P<0.01 vs. Cont or 0 h. Cont, control; Aβ-42, amyloid β-42.

Transcription and expression of mitochondrial fission and fusion proteins after Aβ-42 treatment. mRNA expression levels of (A) Drp1 and (B) Mfn1, Mfn2 and OPA-1. (C) Representative western blot images and (D) quantification of Drp1, Mfn1, Mfn2 and OPN-1 protein expression levels. GAPDH served as an endogenous control. Data are presented as the mean ± standard deviation of at least three independent experiments. *P<0.05, **P<0.01 vs. 0 h. Aβ-42, amyloid β-42; Drp1, dynamin-related protein 1; Mfn, mitofusin; OPA-1, mitochondrial dynamin like GTPase.

Effect of Aβ-42 on mitochondrial fission and intracellular ROS production. (A) Mitochondrial morphology in neurons pre- and post-treatment with Aβ-42. Scale bar=5 µm. (B) Effect of Aβ-42 on intracellular ROS production. Scale bar=20 µm. ROS, reactive oxygen species; Aβ-42, amyloid β-42.

Aβ-42 disrupts mitochondrial membrane potential and upregulates expression of LC3B and Pink1. (A) Effect of Aβ-42 on mitochondrial membrane potential in neurons, as assessed by tetramethylrhodamine ethyl ester staining. Scale bar=20 µm. (B) Representative western blot images and (C) quantification of protein expression levels of LC3B and Pink1 after Aβ-42 treatment. GAPDH was used as an endogenous control. Data are presented as the mean ± standard deviation of at least three independent experiments. *P<0.05 vs. 0 h. Aβ-42, amyloid β-42; LC3B, microtubule-associated proteins 1A/1B light chain 3B.